VRDN
Viridian Therapeutics Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing | |||||||||||||
| Capital Expenditures | 495,000 | 511,000 | 898,000 | 797,000 | 338,000 | 42,000 | 84,000 | 445,000 | 246,000 | 250,000 | 123,000 | 266,000 | 5,000 |
| Acquisitions | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing | |||||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Summary | |||||||||||||
| Free Cash Flow | -276.9M | -232.8M | -185.1M | -94.6M | -54.9M | -29.8M | -36.1M | -27.3M | -28.4M | -15.0M | -7.0M | -2.5M | -1.2M |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — | — | — | — |